Skip to main content

Reducing Drug Waste Through Dose Rounding of Bevacizumab With Puneeth Indurlal, MD

In this interview from the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, Dr. Puneeth Indurlal, Senior Director for Care Transformation at the US Oncology Network, discusses his team's abstract regarding dose rounding of bevacizumab, the potential for minimizing drug waste, and reducing the cost of care.  

Continue reading

Renal Cell Carcinoma Research and Shared Decision Making With Bradley McGregor, MD

Oncology Data Advisor® · Renal Cell Carcinoma Research and Shared Decision Making With Bradley McGregor, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® sat down with Bradley McGregor, MD, Director of Clinical Research for the Lank Center of Genitourinary Oncology at the Dana-Farber Cancer Institute, to discuss his presentation regarding the results of the phase 2 study of cabozantinib (cabo) with nivolumab (nivo) an...

Continue reading

Exploring the Primary Overall Survival Results of Axicabtagene Ciloleucel in the ZUMA-7 Trial With Jason Westin, MD

At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Jason Westin, Director of Lymphoma Clinical Research at MD Anderson Cancer Center, presented the primary overall survival analysis of the phase 3 ZUMA-7 trial investigating axicabtagene ciloleucel for relapsed/refractory large B-cell lymphomas. In this interview, he shares more with Oncology Data Advisor regarding the efficacy, safety, and future directions of this promising agent. 

Continue reading

Impacts of Social Determinants of Health on Triple-Negative Breast Cancer Treatment With Nicholas Robert, MD

In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor speaks with Dr. Nicholas Robert, Chief Medical Officer for Ontada, about his team's abstract regarding the impacts of social determinants of health on genetic testing and treatment selection in triple-negative breast cancer (TNBC).  

Continue reading

Trastuzumab Deruxtecan Safety in HER2-Expressing Solid Tumors With Funda Meric-Bernstam, MD

Oncology Data Advisor® · Trastuzumab Deruxtecan Safety on HER2 Expressing Solid Tumors With Funda Meric-Bernstam, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Funda Meric-Bernstam, the Department Chair in the Department of Vascular Cancer Therapeutics at MD Anderson Cancer Center, sat down with Oncology Data Advisor to discuss her presentation of the results of the Destiny-PanTumor-02 trial, in which her team studied the safety of trastuzumab ...

Continue reading

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD, Editor in Chief

Hot enough for ya? While large swaths of the United States bake in an unrelenting summer heat wave, Oncology Data Advisor is having quite a summer hot streak of our own. We are honored to have received an APEX Award of Excellence for Health and Medical Websites. This is an extraordinary achievement that reflects the creativity and dedication of the OncData Editorial Board, who strive every day to bring the website's readership the most up-to-date and relevant opinions and information from the bl...

Continue reading

Partnering With Patients Through Advocacy With Allison Rosen, MS

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Allison Rosen, a colorectal cancer survivor, patient advocate, and Director of Project ECHO for the American Cancer Society. Ms. Rosen shares the story of her cancer journey, how she became involved in patient advocacy, and how to strives to use her platform to bridge the gap between clinical research and cancer patients and survivors.  

Continue reading

Expanding Global Health Education Through Video and Social Media With Yan Leyfman, MD

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down with Dr. Yan Leyfman, a physician at Mount Sinai Hospital and Director and Host of MedNews Week. Dr. Leyfman explains the origin and reach of MedNews Week and how it strives to combat health care information, champion patient advocacy, and expand global health education through its video and social media platforms.  

Continue reading

Studying Accelerated Brain Age and Neurocognitive Impairments in Childhood Cancer Survivors With Nicholas Phillips, MD, PhD

In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Nicholas Phillips, a Physician Scientist at St. Jude Children's Research Hospital, discusses his research investigating accelerated brain age and associated neurocognitive impairments experienced by childhood cancer survivors.  

Continue reading

Supporting Patients Through Employment Disruptions During Cancer With Michael Halpern, MD, PhD, MPH

In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Michael Halpern, Medical Officer in the National Cancer Institute's Healthcare Delivery Research Program, discusses his team's study investigating the effects of employment disruptions on financial hardship experienced by patients with cancer. Dr. Halpern shares advice for how employers can provide support and accommodation in the workplace for their employees during cancer treatment, as well as advice for clinicians on how to partner with patients to address financial hardships.  

Continue reading

Pickles Group: Supporting Kids Impacted by Parental Cancer With Cassy Horton, Executive Director

In this interview from the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor speaks with Cassy Horton, Executive Director of Pickles Group, a nonprofit organization supporting the social and emotional wellbeing of children whose parents have cancer.  

Continue reading

Partnering With Patients Through Advocacy With Allison Rosen, MS

Oncology Data Advisor® · Partnering With Patients Through Advocacy With Allison Rosen At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Allison Rosen, a colorectal cancer survivor, patient advocate, and Director of Project ECHO for the American Cancer Society. Ms. Rosen shares the story of her cancer journey, how she became involved in patient advocacy, and how she strives to use her platform to bridge the gap between cli...

Continue reading

Coaching Cancer Survivors Through Digital Health With Robin Lally, PhD, and Marilyn Hammer, PhD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Robin Lally, PhD, and Marilyn Hammer, PhD, co–Principal Investigators of the COACH (Comprehensive Outcomes for After-Cancer Health) study. Dr. Lally and Dr. Hammer share the background of this study and how it is seeking to improve the cancer survivorship experience through digital health interventions and patient-reported outcomes.  

Continue reading

Coaching Cancer Survivors Through Digital Health With Robin Lally, PhD, and Marilyn Hammer, PhD

Oncology Data Advisor® · Coaching Cancer Survivors Through Digital Health: Robin Lally, PhD, and Marilyn Hammer, PhD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Robin Lally, PhD, and Marilyn Hammer, PhD, co–Principal Investigators of the COACH (Comprehensive Outcomes for After-Cancer Health) study. Dr. Lally and Dr. Hammer share the background of this study and how it is seeking to improve...

Continue reading

Improving Access to Hereditary Cancer Genetic Testing for Black Individuals and Their Families With Darya Kizub, MD

At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Darya Kizub, Hematology-Oncology Fellow at MD Anderson Cancer Center, presented her team's research regarding a novel initiative for recruiting Black individuals to be screened for hereditary cancer genetic testing eligibility. Prior to presenting, she sat down with Oncology Data Advisor to share more about the need to provide cancer genetic testing for Black individuals and the ways that she and her team have partnered with the community to enact this change.  

Continue reading

Expanding Global Health Education Through Video and Social Media With Yan Leyfman, MD

Oncology Data Advisor® · Expanding Global Health Education Through Video and Social Media With Yan Leyfman, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down with Dr. Yan Leyfman, a physician at Mount Sinai Hospital and Director and Host of MedNews Week. Dr. Leyfman explains the origin and reach of MedNews Week and how it strives to combat health care information, champion patient advocacy, and expand global health ed...

Continue reading

Social Determinants of Health and Genetic Testing in Triple-Negative Breast Cancer With Barb Kunz, MS, LCGC

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor® sat down with Barb Kunz, a Senior Genetic Counselor at the US Oncology Network, to talk about her research on rates of germline testing for BRCA1 and BRCA2 mutations in patients with triple-negative breast cancers and her presentation on the impacts of social determinants of health on genetic testing.  

Continue reading

Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr. Thomas Abrams, Editor in Chief

Oncology Data Advisor® · Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr.Thomas Abrams At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Thomas Abrams, Editor in Chief of Oncology Data Advisor, previewed some of the latest updates on Oncology Data Advisor and the new directions that will be taken in 2023, including new ways of partnering with patients to strengthen the patient voice and ultimately improve quality of ...

Continue reading

Results of the HERIZON-BTC-01 Trial of Zanidatamab in Biliary Tract Cancers With Shubham Pant, MD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Shubham Pant, Associate Professor in the Department of Medical Oncology at MD Anderson Cancer Center, presented the results of HERIZON-BTC-01, a phase 2b trial investigating zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)–amplified biliary tract cancers. Afterwards he spoke with Oncology Data Advisor to share more about the efficacy, safety, and future directions for zanidatamab. 

Continue reading

An Exclusive Playlist From the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® had the privilege of interviewing many distinguished physician, nurse, pharmacist, pathologist, and patient advocate speakers about their work and research. This playlist features video and podcast conversations on topics including shared decision making in renal cell carcinoma, nursing research regarding digital health for cancer survivors, social determinants of health in genetic testing for triple-negative breast cancer, an exclusive conversation with OncData's Editor in Chief, Dr. Thomas Abrams, and much more! 

Continue reading